Clinical Trials
3 trialsNCT01372618 2017-12-27
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
NYU Langone Health
Phase 1/2 Terminated
NCT01356862 2017-01-25
SOM 230
Alliance Pour La Recherche en Cancerologie
Phase 2 Completed
NCT01372644 2016-12-05
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
NYU Langone Health
Phase 1 Completed